{"id":"https://openalex.org/W2109748130","doi":null,"title":"Attenuation of cytogenetic damage by 2-mercaptoethanesulfonate in cultured human lymphocytes exposed to cyclophosphamide and its reactive metabolites.","display_name":"Attenuation of cytogenetic damage by 2-mercaptoethanesulfonate in cultured human lymphocytes exposed to cyclophosphamide and its reactive metabolites.","publication_year":1986,"publication_date":"1986-01-01","ids":{"openalex":"https://openalex.org/W2109748130","mag":"2109748130","pmid":"https://pubmed.ncbi.nlm.nih.gov/3079586"},"language":"en","primary_location":{"id":"pmid:3079586","doi":null,"is_oa":false,"landing_page_url":"https://pubmed.ncbi.nlm.nih.gov/3079586","pdf_url":null,"source":{"id":"https://openalex.org/S4306525036","display_name":"PubMed","issn_l":null,"issn":null,"is_oa":false,"is_in_doaj":false,"is_core":false,"listed_in":[],"host_organization":"https://openalex.org/I1299303238","host_organization_name":"National Institutes of Health","host_organization_lineage":["https://openalex.org/I1299303238"],"host_organization_lineage_names":[],"type":"repository"},"license":null,"license_id":null,"version":"publishedVersion","is_accepted":true,"is_published":true,"raw_source_name":"Cancer research","raw_type":"Journal Article"},"volume":null,"type":"article","is_traditional":true,"indexed_in":["pubmed"],"open_access":{"is_oa":false,"oa_status":"closed","oa_url":null,"any_repository_has_fulltext":false},"authorships":[{"author_position":"first","author":{"id":"https://openalex.org/A5020740452","display_name":"James L. Wilmer","orcid":null,"observed_orcids":[]},"institutions":[],"countries":[],"is_corresponding":false,"raw_author_name":"J L Wilmer","raw_affiliation_strings":[],"raw_orcid":null,"affiliations":[]},{"author_position":"middle","author":{"id":"https://openalex.org/A5111684878","display_name":"Gregory L. Erexson","orcid":null,"observed_orcids":[]},"institutions":[],"countries":[],"is_corresponding":false,"raw_author_name":"G L Erexson","raw_affiliation_strings":[],"raw_orcid":null,"affiliations":[]},{"author_position":"last","author":{"id":"https://openalex.org/A5086718525","display_name":"Andrew D. Kligerman","orcid":null,"observed_orcids":[]},"institutions":[],"countries":[],"is_corresponding":false,"raw_author_name":"A D Kligerman","raw_affiliation_strings":[],"raw_orcid":null,"affiliations":[]}],"institutions":[],"countries_distinct_count":0,"institutions_distinct_count":0,"corresponding_author_ids":[],"corresponding_institution_ids":[],"apc_list":null,"apc_paid":null,"fwci":1.2157,"has_fulltext":false,"cited_by_count":34,"citation_normalized_percentile":{"value":0.75348922,"is_in_top_1_percent":false,"is_in_top_10_percent":false},"cited_by_percentile_year":{"min":88,"max":98},"biblio":{"volume":"46","issue":"1","first_page":"203","last_page":"10"},"is_retracted":false,"is_paratext":false,"is_xpac":false,"primary_topic":{"id":"https://openalex.org/T10433","display_name":"Carcinogens and Genotoxicity Assessment","score":0.9878000020980835,"subfield":{"id":"https://openalex.org/subfields/1306","display_name":"Cancer Research"},"field":{"id":"https://openalex.org/fields/13","display_name":"Biochemistry, Genetics and Molecular Biology"},"domain":{"id":"https://openalex.org/domains/1","display_name":"Life Sciences"}},"topics":[{"id":"https://openalex.org/T10433","display_name":"Carcinogens and Genotoxicity Assessment","score":0.9878000020980835,"subfield":{"id":"https://openalex.org/subfields/1306","display_name":"Cancer Research"},"field":{"id":"https://openalex.org/fields/13","display_name":"Biochemistry, Genetics and Molecular Biology"},"domain":{"id":"https://openalex.org/domains/1","display_name":"Life Sciences"}},{"id":"https://openalex.org/T12356","display_name":"Bioactive Compounds and Antitumor Agents","score":0.005900000222027302,"subfield":{"id":"https://openalex.org/subfields/3005","display_name":"Toxicology"},"field":{"id":"https://openalex.org/fields/30","display_name":"Pharmacology, Toxicology and Pharmaceutics"},"domain":{"id":"https://openalex.org/domains/1","display_name":"Life Sciences"}},{"id":"https://openalex.org/T11359","display_name":"Effects of Radiation Exposure","score":0.0013000000035390258,"subfield":{"id":"https://openalex.org/subfields/2741","display_name":"Radiology, Nuclear Medicine and Imaging"},"field":{"id":"https://openalex.org/fields/27","display_name":"Medicine"},"domain":{"id":"https://openalex.org/domains/4","display_name":"Health Sciences"}}],"keywords":[{"id":"https://openalex.org/keywords/cyclophosphamide","display_name":"cyclophosphamide","score":0.9380000233650208},{"id":"https://openalex.org/keywords/2-mercaptoethanesulfonate","display_name":"2-mercaptoethanesulfonate","score":0.8949999809265137},{"id":"https://openalex.org/keywords/phosphoramide-mustard","display_name":"phosphoramide mustard","score":0.781000018119812},{"id":"https://openalex.org/keywords/acrolein","display_name":"acrolein","score":0.9990000128746033},{"id":"https://openalex.org/keywords/chromosomal-damage","display_name":"chromosomal damage","score":0.7680000066757202},{"id":"https://openalex.org/keywords/sister-chromatid-exchange","display_name":"sister chromatid exchange","score":0.8059999942779541},{"id":"https://openalex.org/keywords/chromosomal-abnormalities","display_name":"chromosomal abnormalities","score":0.9179999828338623},{"id":"https://openalex.org/keywords/clastogenicity","display_name":"clastogenicity","score":0.9160000085830688},{"id":"https://openalex.org/keywords/cytotoxicity","display_name":"cytotoxicity","score":0.7739999890327454},{"id":"https://openalex.org/keywords/lymphocytes","display_name":"lymphocytes","score":0.5540000200271606}],"concepts":[{"id":"https://openalex.org/C2780376820","wikidata":"https://www.wikidata.org/wiki/Q424997","display_name":"Mesna","level":5,"score":0.8326146006584167},{"id":"https://openalex.org/C19869320","wikidata":"https://www.wikidata.org/wiki/Q419277","display_name":"Concanavalin A","level":3,"score":0.7307806015014648},{"id":"https://openalex.org/C109316439","wikidata":"https://www.wikidata.org/wiki/Q246181","display_name":"Cytotoxicity","level":3,"score":0.6699633002281189},{"id":"https://openalex.org/C185592680","wikidata":"https://www.wikidata.org/wiki/Q2329","display_name":"Chemistry","level":0,"score":0.5471760630607605},{"id":"https://openalex.org/C117262875","wikidata":"https://www.wikidata.org/wiki/Q5135057","display_name":"Clonogenic assay","level":3,"score":0.45978692173957825},{"id":"https://openalex.org/C202751555","wikidata":"https://www.wikidata.org/wiki/Q221681","display_name":"In vitro","level":2,"score":0.44188278913497925},{"id":"https://openalex.org/C153911025","wikidata":"https://www.wikidata.org/wiki/Q7202","display_name":"Molecular biology","level":1,"score":0.44062840938568115},{"id":"https://openalex.org/C98274493","wikidata":"https://www.wikidata.org/wiki/Q128406","display_name":"Pharmacology","level":1,"score":0.3965025842189789},{"id":"https://openalex.org/C55493867","wikidata":"https://www.wikidata.org/wiki/Q7094","display_name":"Biochemistry","level":1,"score":0.30275875329971313},{"id":"https://openalex.org/C86803240","wikidata":"https://www.wikidata.org/wiki/Q420","display_name":"Biology","level":0,"score":0.280342698097229},{"id":"https://openalex.org/C2778239845","wikidata":"https://www.wikidata.org/wiki/Q412415","display_name":"Cisplatin","level":3,"score":0.19174131751060486},{"id":"https://openalex.org/C126322002","wikidata":"https://www.wikidata.org/wiki/Q11180","display_name":"Internal medicine","level":1,"score":0.16778290271759033},{"id":"https://openalex.org/C2776694085","wikidata":"https://www.wikidata.org/wiki/Q974135","display_name":"Chemotherapy","level":2,"score":0.1411937177181244},{"id":"https://openalex.org/C71924100","wikidata":"https://www.wikidata.org/wiki/Q11190","display_name":"Medicine","level":0,"score":0.13994768261909485},{"id":"https://openalex.org/C2777506904","wikidata":"https://www.wikidata.org/wiki/Q418560","display_name":"Ifosfamide","level":4,"score":0.10990449786186218}],"mesh":[{"descriptor_ui":"D000171","descriptor_name":"Acrolein","qualifier_ui":"Q000037","qualifier_name":"antagonists & inhibitors","is_major_topic":false},{"descriptor_ui":"D000171","descriptor_name":"Acrolein","qualifier_ui":"Q000633","qualifier_name":"toxicity","is_major_topic":false},{"descriptor_ui":"D002453","descriptor_name":"Cell Cycle","qualifier_ui":"Q000187","qualifier_name":"drug effects","is_major_topic":false},{"descriptor_ui":"D002478","descriptor_name":"Cells, Cultured","qualifier_ui":null,"qualifier_name":null,"is_major_topic":false},{"descriptor_ui":"D002869","descriptor_name":"Chromosome Aberrations","qualifier_ui":null,"qualifier_name":null,"is_major_topic":false},{"descriptor_ui":"D003520","descriptor_name":"Cyclophosphamide","qualifier_ui":"Q000037","qualifier_name":"antagonists & inhibitors","is_major_topic":false},{"descriptor_ui":"D003520","descriptor_name":"Cyclophosphamide","qualifier_ui":"Q000633","qualifier_name":"toxicity","is_major_topic":true},{"descriptor_ui":"D004305","descriptor_name":"Dose-Response Relationship, Drug","qualifier_ui":null,"qualifier_name":null,"is_major_topic":false},{"descriptor_ui":"D006801","descriptor_name":"Humans","qualifier_ui":null,"qualifier_name":null,"is_major_topic":false},{"descriptor_ui":"D008623","descriptor_name":"Mercaptoethanol","qualifier_ui":"Q000031","qualifier_name":"analogs & derivatives","is_major_topic":true},{"descriptor_ui":"D008940","descriptor_name":"Mitotic Index","qualifier_ui":"Q000187","qualifier_name":"drug effects","is_major_topic":false},{"descriptor_ui":"D009152","descriptor_name":"Mutagenicity Tests","qualifier_ui":null,"qualifier_name":null,"is_major_topic":false},{"descriptor_ui":"D010752","descriptor_name":"Phosphoramide Mustards","qualifier_ui":"Q000037","qualifier_name":"antagonists & inhibitors","is_major_topic":false},{"descriptor_ui":"D010752","descriptor_name":"Phosphoramide Mustards","qualifier_ui":"Q000633","qualifier_name":"toxicity","is_major_topic":false},{"descriptor_ui":"D012854","descriptor_name":"Sister Chromatid Exchange","qualifier_ui":"Q000187","qualifier_name":"drug effects","is_major_topic":false},{"descriptor_ui":"D013601","descriptor_name":"T-Lymphocytes","qualifier_ui":"Q000187","qualifier_name":"drug effects","is_major_topic":false},{"descriptor_ui":"D015080","descriptor_name":"Mesna","qualifier_ui":"Q000494","qualifier_name":"pharmacology","is_major_topic":true}],"locations_count":2,"locations":[{"id":"pmid:3079586","doi":null,"is_oa":false,"landing_page_url":"https://pubmed.ncbi.nlm.nih.gov/3079586","pdf_url":null,"source":{"id":"https://openalex.org/S4306525036","display_name":"PubMed","issn_l":null,"issn":null,"is_oa":false,"is_in_doaj":false,"is_core":false,"listed_in":[],"host_organization":"https://openalex.org/I1299303238","host_organization_name":"National Institutes of Health","host_organization_lineage":["https://openalex.org/I1299303238"],"host_organization_lineage_names":[],"type":"repository"},"license":null,"license_id":null,"version":"publishedVersion","is_accepted":true,"is_published":true,"raw_source_name":"Cancer research","raw_type":"Journal Article"},{"id":"mag:2109748130","doi":null,"is_oa":false,"landing_page_url":"https://pubmed.ncbi.nlm.nih.gov/3079586","pdf_url":null,"source":{"id":"https://openalex.org/S4306525036","display_name":"PubMed","issn_l":null,"issn":null,"is_oa":false,"is_in_doaj":false,"is_core":false,"listed_in":[],"host_organization":"https://openalex.org/I1299303238","host_organization_name":"National Institutes of Health","host_organization_lineage":["https://openalex.org/I1299303238"],"host_organization_lineage_names":[],"type":"repository"},"license":null,"license_id":null,"version":null,"is_accepted":false,"is_published":false,"raw_source_name":"PubMed","raw_type":null}],"best_oa_location":null,"sustainable_development_goals":[{"display_name":"Good health and well-being","id":"https://metadata.un.org/sdg/3","score":0.9789000153541565}],"study_designs":[],"awards":[],"funders":[],"has_content":{"grobid_xml":false,"pdf":false},"content_urls":null,"referenced_works_count":18,"referenced_works":["https://openalex.org/W575014383","https://openalex.org/W1518545470","https://openalex.org/W1562960614","https://openalex.org/W1582189787","https://openalex.org/W1587942381","https://openalex.org/W1990144511","https://openalex.org/W2001467107","https://openalex.org/W2015638728","https://openalex.org/W2074795894","https://openalex.org/W2078890282","https://openalex.org/W2082947321","https://openalex.org/W2091884801","https://openalex.org/W2111989572","https://openalex.org/W2121606986","https://openalex.org/W2150007059","https://openalex.org/W2282746592","https://openalex.org/W2414940207","https://openalex.org/W2417252106"],"related_works":["https://openalex.org/W2013232065","https://openalex.org/W2035452350","https://openalex.org/W1974685516","https://openalex.org/W2397163259","https://openalex.org/W1930738835","https://openalex.org/W2429381984","https://openalex.org/W1986269821","https://openalex.org/W2036685209","https://openalex.org/W2065141507","https://openalex.org/W2015638728"],"abstract_inverted_index":{"Cyclophosphamide":[0],"(CP)":[1],"is":[2],"metabolized":[3],"to":[4,29,44,78,94,134,143,162,269,315,322,336,355],"the":[5,53,71,90,96,182,201,232,239,278,291,337,347],"reactive":[6,363],"intermediates,":[7],"phosphoramide":[8],"mustard":[9],"(PAM)":[10],"and":[11,50,60,76,82,99,106,113,160,218,226,235,249,257,271,359],"acrolein":[12],"(AC),":[13],"which":[14,120],"have":[15],"generally":[16],"different":[17],"molecular":[18],"binding":[19],"targets.":[20],"Sodium":[21],"2-mercaptoethanesulfonic":[22],"acid":[23],"(MESNA)":[24],"has":[25,37],"been":[26],"used":[27],"clinically":[28],"alleviate":[30],"hemorrhagic":[31],"cystitis":[32],"caused":[33],"by":[34,56,102,149,238,251,362],"CP":[35,45,163,364],"chemotherapy,":[36],"exhibited":[38],"anticarcinogenic":[39],"effects":[40,339],"in":[41,52,84,181,200,262,266,305,319],"rats":[42],"exposed":[43,161,268,321],"during":[46,141],"a":[47,135],"long-term":[48],"bioassay,":[49],"acts":[51],"urogenital":[54],"tract":[55],"reacting":[57],"with":[58,157,288,290,298,329,352],"4'-OH-CP":[59],"AC.":[61],"The":[62,308],"purpose":[63],"of":[64,74,92,137,186,277,301,313,340,349],"this":[65],"study":[66],"was":[67,207,215,244,284],"to:":[68],"(a)":[69],"compare":[70],"relative":[72],"abilities":[73],"PAM":[75,144,174,206,214,323],"AC":[77,146,171,248],"induce":[79],"cytogenetic":[80,97,131,233,357],"damage":[81,98,234,358],"cytotoxicity":[83,100,236,289,360],"cultured":[85,138],"human":[86],"lymphocytes;":[87],"(b)":[88],"assess":[89],"efficacy":[91],"MESNA":[93,187,229,350],"attenuate":[95,356],"induced":[101,196,211,237,361],"CP,":[103],"AC,":[104,227],"PAM,":[105,270],"diethyl-4'-hydroperoxycyclophosphamide":[107],"(DEHP-CP),":[108],"an":[109,167,210,275,299],"activated":[110],"AC-generating":[111],"compound;":[112],"(c)":[114],"determine":[115],"if":[116],"concanavalin":[117,158,330],"A-stimulated":[118],"T-lymphocytes,":[119],"differentiate":[121],"into":[122],"suppressor":[123],"cells":[124,140,320],"upon":[125],"lectin":[126],"activation,":[127],"exhibit":[128],"any":[129],"heightened":[130],"sensitivity":[132],"compared":[133],"variety":[136],"mammalian":[139],"exposure":[142],"or":[145,177,184,190],"as":[147],"reported":[148],"other":[150],"investigators.":[151],"Purified":[152],"mononuclear":[153],"leukocytes":[154],"were":[155,224],"stimulated":[156,328],"A":[159,331],"(0.5-2.0":[164],"mM)":[165],"without":[166],"exogenous":[168],"activation":[169],"system,":[170],"(0.001-40.0":[172],"microM),":[173,176],"(0.0014-27.1":[175],"DEHP-CP":[178,225,250],"(0.1-100.0":[179],"microM)":[180],"presence":[183],"absence":[185],"(1,":[188],"5,":[189],"10":[191],"mM).":[192],"All":[193],"four":[194,240,292],"compounds":[195],"significant":[197],"concentration-related":[198],"increases":[199],"SCE":[202,253,282,311],"frequency,":[203],"but":[204,242],"only":[205],"clastogenic.":[208],"On":[209],"SCE/microM":[212],"basis,":[213],"about":[216],"130":[217],"193":[219],"times":[220,317],"more":[221],"potent":[222],"than":[223],"respectively.":[228],"protected":[230],"against":[231,247],"compounds,":[241],"it":[243],"particularly":[245,334],"effective":[246],"abolishing":[252],"induction":[254,264,283,296],"completely.":[255],"SCEs":[256],"chromosome":[258,294],"aberrations":[259],"differed":[260],"considerably":[261],"their":[263],"kinetics":[265,304],"lymphocytes":[267,327],"these":[272,343],"disparities":[273],"suggested":[274],"uncoupling":[276],"two":[279],"phenomena.":[280],"Although":[281],"not":[285],"consistently":[286],"associated":[287],"agents,":[293],"aberration":[295],"coincided":[297],"inhibition":[300],"cell":[302],"cycle":[303],"PAM-treated":[306],"cells.":[307],"exceptionally":[309],"high":[310],"frequency":[312],"up":[314],"21":[316],"baseline":[318],"indicates":[324],"that":[325,346],"T-suppressor":[326],"may":[332],"be":[333],"sensitive":[335],"DNA-damaging":[338],"PAM.":[341],"Finally,":[342],"data":[344],"suggest":[345],"anticarcinogenicity":[348],"correlates":[351],"its":[353],"ability":[354],"metabolites.":[365]},"counts_by_year":[{"year":2023,"cited_by_count":1},{"year":2013,"cited_by_count":2},{"year":2012,"cited_by_count":5}],"updated_date":"2026-10-31T12:09:11.096373","created_date":"2016-06-24T00:00:00"}